Completed

MONITAIR-OSARemote Monitoring for CPAP Adherence in Obstructive Sleep Apnea

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Standard Coaching (SOC)

+ MonitAir RPM

Behavioral
Who is being recruted

Treatment Adherence and Compliance+11

+ Apnea

+ Behavior

Over 18 Years
+13 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: February 2024
See protocol details

Summary

Principal SponsorMonitAir
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: February 5, 2024

Actual date on which the first participant was enrolled.

Obstructive sleep apnea (OSA) is a common sleep disorder that can lead to serious health issues like high blood pressure, heart problems, and diabetes, affecting overall quality of life. The typical treatment involves using a CPAP machine, which helps keep the airway open during sleep. However, many people struggle to keep up with this treatment. This study is exploring whether using a remote patient monitoring platform called MonitAir can help improve how consistently people use their CPAP machines. MonitAir allows healthcare providers to track patients' CPAP use remotely and provide timely support, aiming to enhance patient commitment to treatment and improve health outcomes. Participants in this study are individuals recently diagnosed with OSA who are beginning CPAP therapy. They are divided into two groups: one receives regular coaching, and the other gets additional support through the MonitAir platform. This platform includes weekly reviews of CPAP data, automated messages, monthly telehealth check-ins, and extra doctor consultations if needed. The study measures how often participants use their CPAP machines over 30, 60, and 90 days, based on specific guidelines. It also looks at other factors like patient satisfaction, quality of sleep, and any issues with the CPAP masks. All participants are monitored for typical side effects, with no additional risks expected from using the MonitAir system.

Official TitleAssessing the Utility of a Remote Patient Monitoring Platform for Improving CPAP Adherence for Obstructive Sleep Apnea
NCT07182617
Principal SponsorMonitAir
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

200 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Treatment Adherence and ComplianceApneaBehaviorNervous System DiseasesPatient Acceptance of Health CarePatient ParticipationRespiration DisordersRespiratory Tract DiseasesSleep Apnea SyndromesSleep Wake DisordersHealth BehaviorSleep Apnea, ObstructiveSleep Disorders, IntrinsicDyssomnias

Criteria

8 inclusion criteria required to participate
Adults ≥18 years old

Access to a smartphone (iOS or Android)

Ability to engage in two-way text communication and audiovisual conferencing

Home sleep test (HST) or polysomnogram (PSG) performed ≤90 days before randomization

Show More Criteria

5 exclusion criteria prevent from participating
Department of Transportation (DOT) drivers

Central sleep apnea or Cheyne-Stokes respirations (CSA/CSR) ≥10% of diagnostic study

Central or mixed apneas ≥25% of AHI

Use of BiPAP, BiPAP ST, ASV, AVAPS, or any other non-invasive ventilation modality

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Active Comparator
Participants received the standard BetterNight coaching program for CPAP initiation and adherence. Monitoring was performed using existing systems (ResMed AirView, Philips Care Orchestrator, and the internal Clarity dashboard). Coaches contacted patients at scheduled checkpoints (10, 20, 45, 60, and 80 days) and provided support as needed to help patients meet Medicare adherence criteria.

Group II

Experimental
Participants received the standard BetterNight coaching program enhanced with the MonitAir RPM platform. MonitAir enabled weekly data reviews, automated text reminders, and at least one interactive telehealth session per month. Alerts for poor adherence, high residual AHI, or mask issues triggered outreach by coaches and escalation to physicians when needed. The goal was to improve CPAP adherence and patient satisfaction through continuous digital monitoring and engagement.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Remote

Miami, United StatesOpen Remote in Google Maps
CompletedOne Study Center